| |
| |
|
| Insider
Information: |
Hamdy Ahmed Md |
| Relationship: |
|
| City: |
Sunnyvale |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
1,630,165 |
|
|
Indirect Shares
|
96,060 |
|
|
| Direct
Value |
$1,181,285 |
|
|
|
Indirect Value
|
$70,124 |
|
|
| Total
Shares |
1,726,225 |
|
|
| Total
Value |
$1,251,409 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
6
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
6
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
-6.0
|
0.0
|
| Percentage
Gain/Loss : |
 -35.4%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Pharmacyclics Inc |
PCYC |
Chief Medical Officer |
2011-04-29 |
11,966 |
2009-10-30 |
0 |
Premium* |
|
|
Vincerx Pharma, Inc |
VINC |
|
2023-08-10 |
1,618,199 |
2023-08-10 |
96,060 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
12 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| VINC |
Vincerx Pharma, Inc |
See Remarks |
• • – |
2023-08-10 |
4 |
B |
$0.96 |
$5,167 |
I/I |
5,400 |
96,060 |
0.01 |
% |
|
| VINC |
Vincerx Pharma, Inc |
See Remarks |
• • – |
2023-08-09 |
4 |
B |
$0.95 |
$15,994 |
I/I |
16,900 |
90,660 |
0.01 |
% |
|
| VINC |
Vincerx Pharma, Inc |
Chief Executive Officer |
• • – |
2022-12-14 |
4 |
B |
$0.87 |
$30,538 |
I/I |
35,280 |
73,760 |
2.66 |
% |
|
| VINC |
Vincerx Pharma, Inc |
Chief Executive Officer |
• • – |
2022-06-23 |
4 |
B |
$1.41 |
$34,137 |
I/I |
24,200 |
38,480 |
2.66 |
% |
|
| VINC |
Vincerx Pharma, Inc |
Chief Executive Officer |
• • – |
2021-12-22 |
4 |
B |
$10.02 |
$64,650 |
I/I |
6,450 |
14,280 |
2.66 |
% |
|
| VINC |
Vincerx Pharma, Inc |
Chief Executive Officer |
• • – |
2021-06-29 |
4 |
B |
$12.77 |
$99,989 |
I/I |
7,830 |
7,830 |
2.66 |
% |
|
| VINC |
Vincerx Pharma, Inc |
President and CEO |
• • • |
2020-12-23 |
4 |
A |
$0.00 |
$0 |
D/D |
1,618,199 |
1,618,199 |
0 |
- |
|
| PCYC |
Pharmacyclics Inc |
Chief Medical Officer |
• – – |
2011-04-29 |
4 |
A |
$1.61 |
$8,050 |
D/D |
5,011 |
11,966 |
0 |
- |
|
| PCYC |
Pharmacyclics Inc |
Chief Medical Officer |
• – – |
2010-10-29 |
4 |
A |
$1.61 |
$7,944 |
D/D |
4,945 |
6,955 |
0 |
- |
|
| PCYC |
Pharmacyclics Inc |
Chief Medical Officer |
• – – |
2010-10-05 |
4 |
AS |
$8.20 |
$123,000 |
D/D |
(15,000) |
2,010 |
0 |
- |
|
| PCYC |
Pharmacyclics Inc |
Chief Medical Officer |
• – – |
2010-10-05 |
4 |
OE |
$0.73 |
$10,950 |
D/D |
15,000 |
17,010 |
0 |
- |
|
| PCYC |
Pharmacyclics Inc |
Chief Medical Officer |
• – – |
2009-10-30 |
4 |
A |
$1.06 |
$1,063 |
D/D |
1,000 |
1,000 |
0 |
- |
|
12 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
